Dacuronium bromide: Difference between revisions
CSV import |
CSV import |
||
| Line 33: | Line 33: | ||
[[Category:Neuromuscular blockers]] | [[Category:Neuromuscular blockers]] | ||
[[Category:Aminosteroids]] | [[Category:Aminosteroids]] | ||
<gallery> | |||
File:Dacuronium_bromide.svg|Dacuronium bromide chemical structure | |||
</gallery> | |||
Latest revision as of 00:00, 25 February 2025
A non-depolarizing neuromuscular blocking agent
| Dacuronium bromide | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Dacuronium bromide is a non-depolarizing neuromuscular blocking agent used in anesthesia to induce muscle relaxation during surgery or mechanical ventilation. It is part of the aminosteroid class of neuromuscular blockers.
Mechanism of Action[edit]
Dacuronium bromide works by competitively inhibiting the action of acetylcholine at the neuromuscular junction. It binds to the nicotinic acetylcholine receptor on the motor end plate, preventing acetylcholine from binding and triggering muscle contraction. This results in muscle paralysis, which is reversible with the administration of acetylcholinesterase inhibitors such as neostigmine.
Pharmacokinetics[edit]
Dacuronium bromide is administered intravenously. It has a rapid onset of action, typically within 2 to 3 minutes, and a duration of action of approximately 30 to 60 minutes. The drug is metabolized in the liver and excreted primarily in the urine.
Clinical Use[edit]
Dacuronium bromide is used in various surgical procedures to facilitate endotracheal intubation and provide muscle relaxation. It is also used in the intensive care setting to facilitate mechanical ventilation in patients who require prolonged respiratory support.
Side Effects[edit]
Common side effects of dacuronium bromide include hypotension, tachycardia, and bronchospasm. Rarely, it may cause anaphylaxis or prolonged neuromuscular blockade, especially in patients with hepatic or renal impairment.
Contraindications[edit]
Dacuronium bromide is contraindicated in patients with known hypersensitivity to the drug or any of its components. Caution is advised in patients with myasthenia gravis or other neuromuscular disorders.
Related pages[edit]
-
Dacuronium bromide chemical structure
